Preventing type 1 diabetes development and preserving beta-cell function
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preventing type 1 diabetes development and preserving beta-cell function
Authors
Keywords
-
Journal
Current Opinion in Endocrinology Diabetes and Obesity
Volume 29, Issue 4, Pages 386-391
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-07-08
DOI
10.1097/med.0000000000000746
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report
- (2021) Andrea Lin et al. DIABETES
- Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial
- (2021) Robin Assfalg et al. DIABETOLOGIA
- Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2021) Matthias von Herrath et al. Lancet Diabetes & Endocrinology
- Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2021) Stephen E Gitelman et al. Lancet Diabetes & Endocrinology
- Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany
- (2020) Anette-Gabriele Ziegler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- C-Peptide Levels in Subjects Followed Longitudinally Before and After Type 1 Diabetes Diagnosis in TrialNet
- (2020) Magdalena M. Bogun et al. DIABETES CARE
- Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis
- (2020) Pia Leete et al. DIABETOLOGIA
- A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates
- (2020) V. M. Stone et al. Science Advances
- Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes
- (2020) Natalie M. Edner et al. NATURE IMMUNOLOGY
- B‐cell helper T cells and type 1 diabetes
- (2020) Céline Vandamme et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
- (2020) Teresa Quattrin et al. NEW ENGLAND JOURNAL OF MEDICINE
- State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
- (2019) Nicole C. Foster et al. Diabetes Technology & Therapeutics
- Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
- (2019) Michael J. Haller et al. DIABETES
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- WITHDRAWN: IDF Diabetes Atlas: Worldwide Estimates of Incidence, Prevalence and Mortality of Type 1 Diabetes in Children and Adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2019) Christopher C. Patterson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The heterogeneous pathogenesis of type 1 diabetes mellitus
- (2019) Jorma Ilonen et al. Nature Reviews Endocrinology
- Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1cin New-Onset Type 1 Diabetes
- (2018) Michael J. Haller et al. DIABETES CARE
- Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type 1 diabetes
- (2018) Linda A DiMeglio et al. LANCET
- Exploring C-peptide loss in type 1 diabetes using growth curve analysis
- (2018) Rachel E. J. Besser et al. PLoS One
- Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
- (2015) Mark R. Rigby et al. JOURNAL OF CLINICAL INVESTIGATION
- GAD-65 autoantibodies and their role as biomarkers of type 1 diabetes and latent autoimmune diabetes in adults (LADA)
- (2014) R. Towns et al. DRUGS OF THE FUTURE
- Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes
- (2014) Michael J. Haller et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune therapy for treating type 1 diabetes: challenging existing paradigms
- (2014) Jay S. Skyler JOURNAL OF CLINICAL INVESTIGATION
- A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role
- (2014) Mirella P. Hage et al. Therapeutic Advances in Endocrinology and Metabolism
- Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- (2013) W. Hagopian et al. DIABETES
- Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
- (2013) Tihamer Orban et al. DIABETES CARE
- GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
- (2012) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Primary Dietary Intervention Study to Reduce the Risk of Islet Autoimmunity in Children at Increased Risk for Type 1 Diabetes: The BABYDIET study
- (2011) S. Hummel et al. DIABETES CARE
- No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)
- (2011) M. Simpson et al. DIABETOLOGIA
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- New Definition for the Partial Remission Period in Children and Adolescents With Type 1 Diabetes
- (2009) H. B. Mortensen et al. DIABETES CARE
- Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study
- (2009) L. Mastrandrea et al. DIABETES CARE
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viral Trigger for Type 1 Diabetes: Pros and Cons
- (2008) C. M. Filippi et al. DIABETES
- Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
- (2008) Kirsti Näntö-Salonen et al. LANCET
- Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice
- (2008) C. Louvet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now